Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hayley, McKee"'
Autor:
Hayley McKee, Lihi Eder, Dana Jerome, Reza D Mirza, Chikaodili Obetta, Elisabeth Pek, Vincent Piguet, Raed Alhusayen
Publikováno v:
JMIR Dermatology, Vol 7, p e58989 (2024)
The prevalence of and factors associated with musculoskeletal (MSK) symptoms in patients with hidradenitis suppurativa (HS) have yet to be elucidated. Given the association between HS and inflammatory comorbidities, understanding the burden of MSK sy
Externí odkaz:
https://doaj.org/article/4b041368ab2c4278b27fa688d8723013
Autor:
Joao Francisco Matos, MD, Hayley McKee, MSc, Christopher McIntosh, William Warnica, Rachel Wald, MD, Kate Hanneman, MD, MPH
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100160- (2024)
Externí odkaz:
https://doaj.org/article/1b71e97069ce418ea04c9136d8538577
Autor:
Hayley McKee, Basem Gohar, Ryan Appleby, Behdin Nowrouzi-Kia, Briana N. M. Hagen, Andria Jones-Bitton
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Higher psychosocial work demands in veterinary and academic professions are associated with decreased occupational, physical, and mental well-being. COVID-19 introduced far-reaching challenges that may have increased the psychosocial work demands for
Externí odkaz:
https://doaj.org/article/af7865b724ed4d1ea21c4c7dc3a240fb
Autor:
Michael A, Singer, David S, Boyer, Stuart, Williams, Hayley, McKee, Kevin, Kerr, Tyler, Pegoraro, Leo, Trevino, Casey C, Kopczynski, David A, Hollander
Publikováno v:
Retina. 43:25-33
AR-1105 is a novel biodegradable sustained-release dexamethasone implant designed to deliver 6-month durability. This Phase 2 study evaluated two AR-1105 formulations with different release profiles in patients with macular edema due to retinal vein
Autor:
Roisin M. Heaney, Kaitlin M. Zaki-Metias, Hayley McKee, Huijuan Wang, Barakat Ogunde, Charlotte J. Yong-Hing, Vivianne Freitas, Sandeep Ghai, Jean M. Seely, Elsie T. Nguyen
Publikováno v:
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
Background: Breast arterial calcification (BAC) on mammography correlates with increased cardiovascular risk. Reporting BAC is not standard practice. Our study evaluates the awareness of Canadian radiologists who report mammography of the clinical si
Publikováno v:
Veterinary Record. 192
Although burnout is often discussed as 'present' or 'not-present', the conceptual framework of an engagement-burnout continuum is more accurate and useful. Recognition of individuals' transitional states of burnout also allows for earlier detection o
Autor:
Arash Kazemi, Katy C. Liu, Theresa Heah, Hayley McKee, Divakar Gupta, Jae Lopez, Pratap Challa, Casey Kopczynski, Arthur J. Sit
Publikováno v:
American Journal of Ophthalmology. 226:262-269
PURPOSE Intraocular pressure (IOP) reduction is key to controlling primary open angle glaucoma (POAG). Pharmacotherapies for POAG or ocular hypertension (OHT) commonly lower IOP by increasing uveoscleral outflow or decreasing aqueous humor production
Autor:
Hayley McKee, Cynthia Walsh, Mana Modares, Wan Wan Yap, Natalia Gorelik, Maura Brown, Charlotte J Yong-Hing, Kate Hanneman
Publikováno v:
Canadian Association of Radiologists Journal. :084653712311706
Objective: To examine differences in fee-for-service (FFS) payments to men and women radiologists in Canada and evaluate potential contributors. Methods: Publicly available FFS radiology billing data was analyzed from British Columbia (BC), Ontario (
Publikováno v:
Ophthalmology and Therapy
Introduction Pharmacotherapy to lower intraocular pressure (IOP) is a mainstay of treatment aimed at delaying progression of visual field loss in ocular hypertension (OHT) and open-angle glaucoma (OAG), but some topical treatments are less effective
Autor:
Casey Kopczynski, Nancy Ramirez, Savak Teymoorian, Richard A Lewis, Dale W. Usner, Hayley McKee, Theresa Heah, Jacob W. Brubaker
Publikováno v:
Ophthalmology Glaucoma. 3:327-338
Purpose A phase 3 trial (MERCURY-1) investigated efficacy and safety of a once-daily, fixed-dose combination (FDC) of netarsudil and latanoprost, compared with each active component, in reducing elevated intraocular pressure (IOP) in patients with op